3-Year Innovation Project is Completed
3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ has been completed. The project aimed to bring digital health solutions to people with dementia, in particular, solutions based on […]
Strong Q4 with Product Launch & Successful Capital Raise
Brain+ announces Investor Webinar following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcements Highlights of Q4 2022 Invitation to Brain+ Q4 investor webinar Brain+ hosts an […]
WHO points to CST to solve the dementia burden
A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia Research, as its first initiative of this kind in the context of non-infectious diseases. In the report, WHO refers to […]
CST Therapist Companion advancing
Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts November 1st in collaboration with a key UK CST researcher, the exact launch timing will be announced later. Brain+ (BRAINP), a pioneer […]
Brain+ begins early activity and brand building in the US
Brain+ begins early activity and brand building in the US The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing Brain+ has been selected and featured as a 2022 TMC-Denmark BioBridge Partner in the new Texas Medical Center (TMC) 2022 Biobridge e-book. TMC is the […]
First milestone met
Brain+ meets milestone with Rox Health (Roche Germany) Rox Health has approved the German version of Brain+’s first digital dementia product, CST-Therapist Companion, for commercial launch. Meeting this milestone unlocks access for Brain+ to additional expert resources in the Rox Health/Roche organization and triggers a minor milestone payment. The following milestones will be product launch […]
Brain+’ new product for dementia launching Q4 2022
Brain+’ new product for dementia launching Q4 2022 Digital “CST–Therapist Companion” is launching one year ahead of plan The Brain+ “CST-Therapist Companion” is a new digital product to deliver Cognitive Stimulation Therapy (CST), a globally recognized evidence-based non-pharmaceutical dementia therapy The Danish market for the Brain+ digital CST products, of which CST-Therapist Companion […]
Germany opens the DiPA reimbursement pathway
Germany opens the DiPA reimbursement pathway to support the adoption of digital health applications, underpinning the value of the #1 target market for Brain+’ first commercial dementia product, CST A significant event for Brain+ as DiPA can provide reimbursement coverage for the first Cognitive Stimulation Therapy (CST) product, expected to be launched in Germany in […]
